144 related articles for article (PubMed ID: 31325182)
21. Human kallikrein 13 expression in salivary gland tumors.
Darling MR; Jackson-Boeters L; Daley TD; Diamandis EP
Int J Biol Markers; 2006; 21(2):106-10. PubMed ID: 16847813
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation.
Jaafari-Ashkavandi Z; Ashraf MJ; Abbaspoorfard AA
Braz J Otorhinolaryngol; 2019; 85(2):144-149. PubMed ID: 29339028
[TBL] [Abstract][Full Text] [Related]
23. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
24. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
Mannweiler S; Beham A; Langner C
APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
[TBL] [Abstract][Full Text] [Related]
25. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
26. Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
Darling MR; Hashem NN; Zhang I; Mohamed AB; Fung K; Kwan K; Mara TW; Daley TD; Diamandis EP
Int J Biol Markers; 2012 Dec; 27(4):e381-8. PubMed ID: 23250777
[TBL] [Abstract][Full Text] [Related]
27. MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Ashkavandi ZJ; Najvani AD; Tadbir AA; Pardis S; Ranjbar MA; Ashraf MJ
Asian Pac J Cancer Prev; 2013; 14(6):3479-82. PubMed ID: 23886132
[TBL] [Abstract][Full Text] [Related]
28. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
29. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
Avadhani V; Cohen C; Siddiqui MT
Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
[TBL] [Abstract][Full Text] [Related]
30. STAT3 expression in salivary gland tumours.
de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
[TBL] [Abstract][Full Text] [Related]
31. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma.
Baba S; Akashi T; Kayamori K; Ohuchi T; Ogawa I; Kubota N; Nakano K; Nagatsuka H; Hasegawa H; Matsuzaka K; Tomii S; Uchida K; Katsuta N; Sekiya T; Ando N; Miura K; Ishibashi H; Ariizumi Y; Asakage T; Michi Y; Harada H; Sakamoto K; Eishi Y; Okubo K; Ikeda T
Pathol Int; 2021 Feb; 71(2):113-123. PubMed ID: 33333616
[TBL] [Abstract][Full Text] [Related]
32. Application of immunohistochemistry to the diagnosis of salivary gland tumors.
de Araújo VC; de Sousa SO; Carvalho YR; de Araújo NS
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):195-202. PubMed ID: 10981871
[TBL] [Abstract][Full Text] [Related]
33. Expression of LC3, LAMP2, KEAP1 and NRF2 in Salivary Adenoid Cystic Carcinoma.
Huang CF; Deng WW; Zhang L; Zhang WF; Sun ZJ
Pathol Oncol Res; 2016 Jan; 22(1):109-14. PubMed ID: 26350055
[TBL] [Abstract][Full Text] [Related]
34. TGFβ signaling pathway in salivary gland tumors.
Gomes ÁNM; Oliveira KK; Marchi FA; Bettim BB; Germano JN; Gonçalves Filho J; Pinto CAL; Lourenço SV; Coutinho-Camillo CM
Arch Oral Biol; 2024 Jun; 162():105943. PubMed ID: 38479278
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma.
Pires FR; da Cruz Perez DE; de Almeida OP; Kowalski LP
Pathol Oncol Res; 2004; 10(3):166-8. PubMed ID: 15448753
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
Safoura S; Mohamad E; Nosrat-Allah E; Fereshte E
J Cancer Res Ther; 2011; 7(1):23-8. PubMed ID: 21546738
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors.
Al-Rawi NH; Omer H; Al Kawas S
J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475
[TBL] [Abstract][Full Text] [Related]
38. Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma.
Zhang MJ; Wang S; Wu CC; Wu L; Sun ZJ
J Oral Pathol Med; 2022 Apr; 51(4):379-387. PubMed ID: 35226778
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like Growth Factor II Messenger RNA-binding Protein 3 in Salivary Gland Tumors.
Ismerim AB; Ferreira SV; Lessa AM; Pereira Júnior AS; Gurgel CA; Coutinho-Camillo CM; Soares FA; Vilas-Bôas DS; Vidal MT; Santos JN
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):422-6. PubMed ID: 26258757
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
